Witness the magical out-of-the-world experience of outer space at the NFT Expoverse, being held at the Los Angeles Convention Center from July 29-31, 2022. Industry leaders, entrepreneurs, techies, visionaries and professionals from the fields of Web 3.0, blockchain, and NFT technologies, are all invited to attend this Expoverse. The Space Giveaway Event Horizon, part of the NFT Expoverse, is a wonderful opportunity for those who have always dreamt of a chance to win a free trip into outer space. The 1st prize of the Space Giveaway (diamond NFT) is an amazing 12-hour space journey, wrapped in a 5-day experience, where the winner will travel in a zero-pressure stratospheric balloon. Spaceflights take off before dawn from World View Spaceports and travel to 100,000 feet above Earth. You can enjoy the edges of outer space for hours as you take in the blackness of space and witness the vast curved expanse of the Earth. It will indeed be the experience of a lifetime, and includes Astronaut Training & Galactic Visionaries Charter Membership. The 2nd place (Platinum NFT) winner will be science popularist Bill Nye’s guest for a special tour of The Planetary Society’s HQ located in the “city of astronomy,” Pasadena, California (flight and hotel stay included). You’ll sip his favorite coffee with Bill, discuss the cosmos and the great questions like “where did we come from?” and “are we alone in the universe?” You’ll leave with a selfie with Bill, cool space swag, and a one-year, mind-expanding Planetary Society membership. The 3rd place winner (Gold NFT) will receive a flying lesson where they will learn to fly and float from an FAA-certified flight instructor. This zero-gravity experience is like no other. Get trained by experts in simulated “zero-g” by flying a series of parabolic flight maneuvers in the Rockwell Commander 700 that counter the forces of gravity. The winner gets to decide the launch date. Experience the weightlessness of space (subject to weather permitting and the availability of the pilot). The event is organized by ZJ Events, a pioneer in hosting conferences and seminars that foster B2B and B2C networking across verticals of the event’s target industry. The event partners are The Planetary Society, Astronaut, Lunar, and World View. The winner must be physically present at NFT Expoverse to accept the Diamond Prize. Winners of the Platinum and Gold prizes can accept their winnings via video call. Winners will be announced live at the event on July 30th, 2022. To participate in the event, purchase your NFT Expoverse tickets and to learn more about the event, please visit https://ibn.fm/SE3Sk.

• Treating patients with primary or secondary bone cancer remains goal, says company CEO
• Radiopharmaceuticals is a new class of drugs that delivers radiation therapy directly to cancer cells
• QSAM is working to develop CycloSam(R) as a breakthrough therapeutic for adult and pediatric bone cancer patients

QSAM Biosciences (OTCQB: QSAM), a company developing a new class of drugs called radiopharmaceuticals, is leading the charge to evaluate a new treatment for bone cancer and other related, underserved diseases. The company’s pioneering efforts are evident as the first patient has completed treatment in the company’s clinical trial designed to study the effect of its proprietary radiopharmaceutical technology: CycloSam(R). “This is an important milestone for QSAM,” said QSAM cofounder and CEO Douglas R. Baum (https://ibn.fm/GcD0R). “Successfully treating patients with primary or secondary bone cancer remains an area of significant unmet medical need and a goal for CycloSam(R).” QSAM received Investigational New Drug Application (“IND”) approval from the U.S. Food and Drug Administration (“FDA”) and shortly thereafter activated its planned phase 1, open-label, dose-escalation, multicenter clinical trial. The trial will study patients who have been diagnosed with bone cancer, including cancer that has metastasized from the lung, breast or prostate, and will evaluate the safety, tolerability, dosimetry and preliminary efficacy of CycloSam. Radiopharmaceuticals is a new class of drugs that delivers radiation therapy directly and specifically to cancer cells. “The last several years have seen an explosion of research and clinical trials testing new radiopharmaceuticals,” reports a recent National Cancer Institute (“NIH”) article (https://ibn.fm/nJsjs). The article noted that radiation therapy was first used to treat cancer more than a century ago, with approximately one-half of all cancer patients still receiving it at some point during their treatment. “Until recently, most radiation therapy was given much as it was 100 years ago, by delivering beams of radiation from outside the body to kill tumors inside the body,” noted the NIH article, which observed that external radiation can cause collateral damage because normal tissue is radiated along with the cancerous tissue. “The resulting side effects of radiation therapy depend on the area of the body treated but can include loss of taste, skin changes, hair loss, diarrhea and sexual problems,” the article continued. New research and studies indicate that “targeting radiation therapy at the cellular level has the potential to reduce the risk of both short- and long-term side effects of treatment while at the same time enabling even tiny deposits of cancer cells to be killed throughout the body.” It is this approach that QSAM focuses on with its lead drug candidate, CycloSam, which is a clinical-stage bone-seeking radiopharmaceutical designed to deliver targeted radiation safely and precisely to tumors in the bone (https://ibn.fm/ZRteN). According to the company, CycloSam delivers Samarium-153, a beta-emitting radioisotope, to areas of rapid bone formation through a superior chelant, DOTMP. The treatment is believed to provide a controlled dose of radiation directly to the tumor environment while minimizing radiation exposure to healthy tissue. The desired goal is tumor regression and increased survival of the patient, results that will be evaluated in the clinical trial process. “Every day our teams are working toward developing CycloSam as a breakthrough therapeutic for cancer patients, both children and adults, male and female, who unfortunately still have poor options and limited long-term survival prognosis,” said Baum. “We look forward to sharing the results of this study with our shareholders and the medical community.” For more information, visit the company’s website at www.QSAMbio.com. NOTE TO INVESTORS: The latest news and updates relating to QSAM are available in the company’s newsroom at http://ibn.fm/QSAM

• Following an international climate agreement in 2015, governments around the world have bound themselves legally to develop, execute, and report on strategies to reduce greenhouse gas pollutants
• The Paris climate agreement envisions pollution reduction by 2050 to such a degree that it will prevent global temperatures from rising more than 1.5 to 2 degrees Celsius above temperature levels about 300 years ago before the Industrial Revolution
• Investors are increasingly using their roles as corporate shareholders to encourage responsibility and active participation in climate change reduction efforts, and that includes financial institutions that provide loans to the fossil fuel industry
• Green energy solutions company Correlate Infrastructure Partners Inc. is helping companies analyze their energy usage, develop ways to improve their buildings’ impact on the environment, and transparently inform shareholders of their progress

When nearly 200 government entities from the world’s international community established a legally binding agreement to combat climate change nearly a decade ago, they set in motion an effort to work cooperatively on making the planet a place where future generations can avoid growing threats from unprecedented shifts in weather patterns (https://ibn.fm/N0Nl1). The goal to prevent increasingly severe weather from significantly altering the course of human history was expressed in terms of reducing the use of man-made pollutants by 2050 enough to keep global temperature increases from peaking beyond more than 1.5 degrees Celsius above where they were in the pre-industrial era nearly 300 years ago. Because pollution-reducing goals necessarily involve buy-in from corporations whose production processes generate pollution, numerous industries have responded by stating efforts to measure and reduce their greenhouse gas emissions, which recently have fallen under the rubric of environmental, social and governance (“ESG”) initiatives (https://ibn.fm/IqCcc). Correlate Infrastructure Partners (OTCQB: CIPI), a purpose-built energy use optimization company based in the United States, has made its mission one of developing green utilities solutions for the commercial real estate industry so that buildings and other corporate facilities will help contribute to a climate solution. The company works to provide advisory assistance on acquisitions and project development to commercial solar industry clients and to back that up with development and financing resources for commercial clients looking for clean energy facility upgrades. CIPI’s subsidiaries, Correlate and Solar Site Design, use data analysis and a commitment to transparency to help their clients achieve clean energy solutions. The international climate accords will begin requiring countries to report transparently on the actions they’ve taken and progress made toward arresting climate change. Climate activists are increasingly calling on the businesses they invest in to account transparently for their greenhouse gas profiles and company efforts at climate change mitigation. “Financial institutions have a key role to play in decarbonizing the global economy and addressing the systemic risks posed by climate change,” comptroller Tom DiNapoli of the New York State Pension Fund told the boards of major banks earlier this year ahead of shareholder votes on resolutions intended to blunt the banks’ underwriting of loans for new fossil fuel development. A report on DiNapoli’s statement noted that the fund oversees $280 billion in investments and has been proactive in supporting climate action (https://ibn.fm/XrmFp). According to the report, Wells Fargo, Citi, Goldman Sachs, and Bank of America, all urged their shareholders not to support the climate proposals, pointing out that, although they continue to support new fossil fuel initiatives presently, they maintain a goal of net-zero greenhouse gas emissions by the year 2050. The climate change proposals failed, as did a similar proposal later. “The path to full decarbonization will take ambition and intentional execution,” CIPI CEO Todd Michaels stated last month, signaling the need for businesses to not only establish plans but execute on them (https://ibn.fm/kNDsM). “By teaming up with industry innovators and experts, we can guide commercial real estate owners in creating new revenue and rent opportunities from their existing energy assets,” he added. For more information, visit the company’s website at www.CorrelateInfra.com, including the following:

• Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income: www.CorrelateInfra.com/our-process
• Platform Generates New Rent And Operating Income, Allowing You To Meet Your ESG Goals: www.CorrelateInfra.com/program

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

• FingerMotion, a U.S.-based communications technology services provider focused on the massive potential of China’s 1.4 billion mobile device user market, reported revenue growth of 37 percent YOY to $22.93 million in its most recent annual financial report
• Company CEO Martin Shen expressed “cautious optimism” that FingerMotion can maintain its momentum, in part because of a ready-to-launch mobile device protection plan similar to AppleCare that the company expects to be competitive in China
• Shen said he also expects the company’s nascent big data product to play a large role in revenue growth in coming years as other industries discover the value of FingerMotion’s first-mover infrastructure in the market
• Thus far, the strength of FingerMotion’s offering has been SMS texting services, user time top-up loading and payment processing, strengthened by a good working relationship with China’s telecommunications giants

Less than two weeks ahead of the newest scheduled report on company earnings, the CEO of mobile technology services provider FingerMotion (NASDAQ: FNGR) is expressing cautious optimism that revenue growth amounting to a 37 percent increase overall during the past year is sustainable, largely through the launch of a device protection solution in the Chinese market to undergird FingerMotion’s existing SMS texting and payment processing capital sources in the Asian juggernaut. In an interview with investor media outlet Proactive, CEO Martin Shen referred to the device protection plan as “in essence AppleCare” for Chinese consumers as far as the design of its operation model — a potentially popular service because device protection “hasn’t really had any sort of cohesive format in China,” he said. FingerMotion is partnering with telecommunications giants China Unicom and China Mobile as well as with a large New York Stock Exchange-listed insurance company eager to break into the Chinese market to provide its new services to consumers. “(China Unicom and China Mobile) have kind of built the AppleCare(-similar) device protection costs into their phone plans,” Shen told Proactive in the interview posted online July 11 (https://ibn.fm/qV8c0). “Now with the massive onset of 5G phones there’s a really large market in China that’s looking to change up their phones for, let’s say, 3G and 4G phones to 5G. So as (consumers) go and get new phones, the cost of this AppleCare(-similar product) is built in,” Shen said. “So that revenue is already there. We’re just going to be partners with the insurance company as well as with the telco. … It’s actually not that capital-intensive for us. It’s a really symbiotic relationship with these companies.” FingerMotion is benefiting from a first-mover status in payments processing and consumer data analysis within China. The company’s big data product, known as Sapientus, has thus far focused on providing predictive services for the reinsurance market as insurance companies seek to establish a system for risk assessment in the country, and FingerMotion expects it to become a big revenue driver within the next couple of years as well. “We’ve had our actuaries, our data scientists working for about two to three years now in building up that wealth of information, so that we’re way ahead of anybody who wants to come in (to the country),” Shen told Proactive. “And also because we have such good relationships with really the largest telcos in China — China Mobile, China Unicom and China Telecom — I think that that kind of relationship lends itself to being very strong footing in terms of working in the Chinese market.” Shen said institutional and retail investors have been looking into the company, not attracted by the stock price so much as FingerMotion’s story and where the company expects to go. “I think our revenue right now is really just the tip of the iceberg, just building on the top-up and the SMS (services),” Shen said. For more information, visit the company’s website at www.FingerMotion.com. NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR

• CPTN produces near-range to ultra-long-range lidar sensors, perception solutions, and software for leading OEM manufacturers across the automotive and smart infrastructure markets
• Cepton aims to make lidar standard in every vehicle to enable safe assisted driving and autonomy
• CPTN’s collaboration with Japan-based Koito Manufacturing Co. Ltd. led to ADAS lidar series production award from General Motors
• Cepton lidar sensors to be used in upcoming GM models featuring its Ultra Cruise advanced driver-assist system starting next year

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, aims to make its proprietary technology standard in all consumer vehicles to support safe and autonomous driving capabilities. Lidar, an acronym for light detection and ranging, uses lasers to scan environments by emitting light to target objects or surfaces and measuring the time it takes for the reflected light to come back to the receiver. The lidar system can then convert the time it takes into a precise measurement of distance between the source and the object or surface. Using multiple lasers, lidar systems can create 3D representations with applications that include measuring the Earth’s surface and ocean floor or helping to enable autonomous vehicles, Advanced Driver-Assistance Systems (“ADAS”), and various smart applications in cities and industrial spaces. Cepton offers a comprehensive suite of near-range to ultra-long-range lidar sensors, perception solutions, and software. The company’s patented Micro Motion Technology (MMT(R)) offers a mirrorless, rotation-free, and frictionless 3D lidar imaging method, enhanced by proprietary micro-optical modules and integrated custom Application-Specific Integrated Circuits (“ASICs”) that offer state-of-the-art illumination control and detection (https://ibn.fm/I6Yvs). CPTN’s technology enables seamless high-volume manufacturing in collaboration with leading Tier 1s. Japan-based Koito Manufacturing Co. Ltd. – the World’s premier Tier 1 auto lighting supplier – invested $50 million through a Series C round in 2020 to support Cepton’s R&D efforts. The collaboration between the two companies resulted in them being awarded the largest ADAS lidar series production award from General Motors, where Cepton lidar sensors will be used in upcoming GM models featuring its new Ultra Cruise advanced driver-assist system (https://ibn.fm/MCv2Y). “We thought ADAS in the near future would be the biggest market for lidar, and that’s why we focused all of our company efforts – whether it’s in technology invention or commercial development – into the ADAS industry,” said CPTN CEO and Co-Founder Dr. Jun Pei in a recent interview with the Financial Times (https://ibn.fm/rgSPP). Koito subsequently invested an additional $50 million via a Private Investment in Public Equity (“PIPE”) transaction in 2021 to support Cepton’s proposed merger. Ties between CPTN and Koito deepened further on June 27, 2022, where both companies jointly announced their intention to expand their existing collaboration efforts to include select future Cepton lidar products and further go-to-market activities. “I am pleased to expand our collaboration beyond the current lidar product for the series production OEM. Koito’s expertise in large-scale manufacturing combined with Cepton’s technological innovation will enable both companies to thrive and allow automotive OEM customers to accelerate lidar adoption and shorten time-to-market for their ADAS offerings,” said Mr. Michiaki Kato, Koito’s President. Since its inception in 2016, Cepton has rapidly advanced lidar research and innovation, which helped the company win the GM ADAS lidar series award shortly after. As a leading innovator of lidar-based solutions for ADAS, AV, and numerous smart applications, Cepton aims to take its patented Micro Motion Technology (MMT(R)) mainstream, enabling scalable and intelligent 3D perception solutions across multiple major global markets. For more information, visit the company’s website at www.Cepton.com. NOTE TO INVESTORS: The latest news and updates relating to CPTN are available in the company’s newsroom at https://ibn.fm/CPTN

• LQwD is leveraging the Lightning Network through its 17 international nodes, with the goal of having 24 nodes by the end of the current quarter
• Active LQwD nodes include Canada, France, Japan, England, Italy, Indonesia, Bahrain, South Africa, South Korea, Sweden, Singapore, Hong Kong, Brazil, Germany, India, Ireland, and US-West
• LQwD released its PaaS offering in November 2021, providing easy node and channel management on the Lightning Network and LSPs for merchants
• The blockchain market is expected to grow at a CAGR of 68.4%, resulting in a projected value of US $67.4 billion by 2026

Despite the volatility of the cryptocurrency market, namely Bitcoin prices falling approximately 38% in June to end the month at less than US $20,000 (https://ibn.fm/npSuj), the Lightning Network sees new all-time highs, boosting scaling capabilities of Bitcoin. The Lightning Network is a layer-2 scaling solution that makes Bitcoin transactions faster and lowers subsequent fees for sending and receiving across the network. The daily average capacity reported has crossed 4,167 BTC, up from the end of June, where reports showed a capacity of 3,962 BTC (https://ibn.fm/W4PjL). LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a financial technology company focused on creating enterprise-grade infrastructure to drive bitcoin adoption, is scaling solutions through the Lightning Network. The company currently has 17 international nodes active on the Lightning Network, including Canada, France, Japan, England, Italy, Indonesia, Bahrain, South Africa, South Korea, Sweden, Singapore, Hong Kong, Brazil, Germany, India, Ireland, and US-West. To follow LQwD’s nodes on the Lightning Network, visit: https://lqwdfintech.com/lightning-netowrk-stats/ . The company released its first node (US-West) in November 2021, alongside its platform as a service (“PaaS”) offering, https://lqwd.tech/. The current capacity of US-West is 6.06271656 BTC (606,271,656 sat/ US $118,154.83); it has over 100 active channels and connected nodes currently operational. Over the last 30 days, US-West has experienced an increase of 0.277324 BTC (+4.79%), an increase of six channels (+5.71%), and a median fee rate of 0.000003 sat. LQwD’s nodes currently operate across 17 countries, but the company’s goal is to expand to 24 by the end of the current quarter. LQwD’s PaaS allows users to manage Lightning Network node hosting and channel management. It is also a liquidity service provider (“LSP”) for merchants, utilizing globally distributed routing nodes through an easy-to-use API. The interface makes it easier for users to send and receive BTC across the Lightning Network, faster and at lower fees than traditional blockchain transactions. The company hopes to achieve accretive growth by targeting up-and-coming Lighting Network projects and LSPs. With different payment facilitators expanding to include blockchain technology, the Lightning Network solves the scalability issues with BTC. Only allowing seven transactions per second (“TPS”), the Bitcoin blockchain (outside of the Lightning Network) requires high fees and slow transaction settlement times. Compared to PayPal (193 TPS) and Visa (24,000 TPS), the Lightning Network exceeds expectations with over one million TPS. The blockchain market size was valued at US $4.9 billion in 2021. It is projected to reach US $67.4 billion by 2026, growing at a CAGR of 68.4% during the forecast period. The primary driving factors for this market include increased interest in venture capital funding, investment in blockchain technology, use of blockchain by banking and cybersecurity industries, and the high adoption of blockchain solutions for payment, smart contracts, and digital identities. Another major contributor to the growth of blockchain (as a whole) is the increased interest of government entities. LQwD is positioned to leverage this market through the use of its international nodes, PaaS offering, and presence in the Bitcoin industry. For more information, visit the company’s website at www.LQwDFinTech.com. NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

• On June 14, Nowigence emerged from being a private company to being publicly listed
• OTCQB Venture Market offers lower cost, complexity than a U.S. exchange listing
• NOWG’s AI knowledge engine mimics the way humans absorb knowledge as they search massive volumes of information

In what the company CEO is calling a historic milestone, Nowigence’s (OTCQB: NOWG), the SaaS technology company behind Pluaris, has begun trading on the OTCQB Venture Market, effective June 14, 2022 (https://ibn.fm/f1nZk). The move comes on the heels of the launch of Pluaris, the company’s comprehensive and turnkey artificial intelligence (“AI”) knowledge engine. “Today, we celebrate a historic milestone in our growth journey that began five years ago,” said Nowigence founder and CEO Anoop Bhatia. “We are emerging from being a private company to being publicly listed. . . . This milestone is a key enabler of our mission to become a leading player in a rapidly growing market, which has a minimum potential $20 billion of serviceable market despite the most conservative lens used for estimating the opportunity size. We thank the entire team at Nowigence for their hard work, as well as our other investors for their support.” OTCQB Venture Market, which is the mid-tier OTC equity market, offers early-stage and developing companies in the United States and international markets the benefits of being publicly traded in the U.S. with lower cost and complexity than a U.S. exchange listing. Trading on the market also provides efficient marketing standards, better information, visibility and better trading (https://ibn.fm/678Pw). Nowigence’s journey to its OTC listing has been marked by the company’s commitment to solve significant problems experienced by earnest individuals seeking to gain knowledge for both professional and personal reasons. Pluaris is NOWG’s answer to data overload, siloed intelligence, scattered information, knowledge loss and duplicate work (https://ibn.fm/qvOou). “Pluaris solves the information overload problem commonly experienced at work and at home,” the company states. “[We believe] the personal knowledge management (‘KM’) market opportunity has over 1 billion users and is currently underserved.” Bhatia noted that the company has committed to helping every user learn more in less time, “thereby solving the information overload problem we all are experiencing at work and at home.” He added, “Pluaris mimics the way we absorb knowledge as individuals while searching through massive volumes of information.” The power of Pluaris comes, in part, from its significant differentiation from other contemporary solutions available in the market. The game-changing app serves individual research scholars, students, journalists and others, saving time as these knowledge seekers pursue information critical to a wide range of uses. In addition, the app is tailored to meet the specific needs of various enterprises and markets, targeting sales teams that are creating customer-centric intelligence dossiers or delivering a transparent and intelligent process connecting corporations, citizens, domain experts, NGOs and philanthropists. In short, the app offers vast functionality, far-reaching benefits and almost-immediate results. Nowigence is an innovative software as a service (“SaaS”) company, focused on developing and bringing to market Pluaris, its comprehensive, ready-to-use artificial intelligence platform. By integrating state-of-the-art data-processing techniques in an intuitive interface at an affordable subscription price, Pluaris puts the power of data science into the hands of consumers. For more information, visit the company’s website at www.Nowigence.com. NOTE TO INVESTORS: The latest news and updates relating to NOWG are available in the company’s newsroom at https://ibn.fm/NOWG

• Researchers have run into the issue of solubility of molecules intended for absorption, ultimately affecting drug effectiveness and inhibiting patient recovery
• This has forced the exploration of new drug delivery technologies, with Lexaria’s patented DehydraTECH(TM) technology proving to be the most innovative, useful, and effective
• DehydraTECH(TM) technology has seen application in oral nicotine for reduced risk, antiviral drugs for COVID-19 and other infectious diseases, PDE5 inhibitors, and CBD for hypertension
• The recent expansion of the Cannadips Brand into Europe, Japan, and South Africa highlights the proliferation of DehydraTECH and a significant growth in its market share, particularly in the CBD space
• Lexaria is excited about the expansion and anticipates additional growth in its technology’s adoption as time progresses

For a long time, the medical industry has sought ways to improve patient health by enhancing the delivery of therapeutic drugs to target sites. An especially critical problem researchers in this sector have encountered is the limited solubility of the molecules intended for absorption. It is estimated that approximately 90% of preclinical drug candidates are low-solubility compounds. This presents a challenge regarding the compounds’ bioavailability and effectiveness of the drugs. The problem has led researchers to explore various drug delivery technologies, some of which have shown promise while others have failed (https://ibn.fm/Dl0rH). Lexaria Bioscience (NASDAQ: LEXX) has come forth with what they are confident is the best solution, their patented DehydraTECH(TM) technology. It has been regarded as one of the most innovative drug delivery technologies in years, proving useful in delivering a wide range of active pharmaceutical ingredients in a more palatable and effective way. In addition, studies repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, a benefit that opens significant possibilities for important drug delivery. DehydraTECH application areas tested so far include CBD for hypertension, oral nicotine for reduced risk, antiviral drugs for COVID-19 and other infectious diseases and PDE5 inhibitors. A new sector showing promise is the CBD industry, valued at $4.1 billion in 2022 and projected to hit $111.8 billion by 2030 (https://ibn.fm/eFGBs). DehydraTECH’s application in the cannabis sector is seeing a boom, particularly with the recent expansion of Boldt Runners Corporation, a DehydraTECH licensee, into Europe, Japan, and South Africa (https://ibn.fm/tOily). Boldt Runners Corporation owns the Cannadips Brand, whose Cannadips CBD dip pouch is the leading CBD pouch brand in the United States. As a tobacco-free, nicotine-free dip alternative, this product offers an effective way to get the benefits of CBD by leveraging Lexaria’s DehydraTECH delivery technology. The product is sold in over 6,500 stores across the United States, and its expansion beyond the country is a major step, not just for Boldt Runners but also for Lexaria. As Lexaria’s list of licensees continues to grow, more consumers will benefit from the DehydraTECH technology. The company is confident that, as the adoption of this technology grows, it will not only help its partners offer clients superior performance and experiences, but also ramp up shareholder value. “Lexaria’s technology is enabling increased market share and sales growth for our continually growing list of corporate clients,” noted Chris Bunka, Lexaria’s Chief Executive Officer (“CEO”). “We are delighted to help these innovators of today and leaders of tomorrow offer their clients superior performance and experiences that competitors simply cannot match, and we are highly anticipatory of additional growth to come,” he added. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Renewable energy production expanded at an annual rate of 15% between 2011 and 2020, and if this growth rate continues through 2035, renewable electricity will meet 100% of the United States’ electricity demand
• In May, California’s renewable energy sources briefly generated 101% of the state’s energy demand
• Correlate Infrastructure Partners provides access to intelligent efficiency measures, electric vehicle (“EV”) infrastructure, and locally sited solar and energy storage
• Through its all-in-one platform, the company designs, engineers, finances, builds, and monitors renewable energy (solar) projects for its clients, enabling them to meet ESG mandates as well as save on electricity costs and capital expenditure (“CapEx”)

A report by a joint team from Frontier Group and Environment America Research and Policy Center, released last year, reported that the proportion of electricity the U.S. generated from wind and solar increased by about four times between 2011 and 2020. Within that decade, wind, solar, and geothermal power production grew at a yearly average of 15%. And should this growth rate continue, renewable energy is projected to meet the country’s electricity demand by 2035 (https://ibn.fm/dD8Xr). The state of California, however, does not have to wait until 2035 as it broke that record earlier in May, albeit briefly. For 15 minutes, the state’s renewable energy generation peaked at 101% of the current energy demand, most of it solar energy, breaking a previous record of 96.4%. And though this does not imply that California was 100% powered by only renewable energy sources – as nuclear, natural gas, and other non-renewable sources also contributed electricity to the grid – the new record marked an important milestone. Against this backdrop, observers now note that stakeholders need to work on ensuring the state runs on 100% clean energy for even longer – a whole day, week, or year (https://ibn.fm/7xa4I). The need for states and countries to run on 100% clean energy has never been more urgent, particularly in the wake of the Paris Agreement and, more recently, the COP26 summit, which amplified calls to mitigate climate change. At the same time, companies are increasingly supporting environmental, social, and governance (“ESG”) initiatives to meet investors’ expectations. Combined, these factors have increased the demand for clean energy sources, with Deloitte’s 2022 Renewable Energy Industry Outlook report noting that renewable energy growth will accelerate this calendar year (https://ibn.fm/XKH5o). Correlate Infrastructure Partners (OTCQB: CIPI), a portfolio-scale development and financing platform providing commercial and industrial facilities access to clean electrification solutions focused on intelligent efficiency measures, electric vehicle (“EV”) infrastructure, and locally sited solar and energy storage, is ideally poised to help countries, states, and companies meet their desired renewable energy targets, starting with its domicile, the United States. By designing, financing, engineering, constructing, and maintaining renewable energy projects, CIPI effectively breaks down barriers to corporate America’s ESG and net operating income (“NOI”) goals. The company’s all-in-one platform incorporates energy experts who develop customized operating strategies that fit clients’ needs; a software application that monitors, measures, and optimizes numerous building performance metrics; vendor management; and financing, to mention a few. “Correlate identifies cash flow positive energy solutions, designs and manages upgrades, and monitors performance over the long haul,” the company’s website reads. Even more impressively, CIPI achieves this without requiring its clients to part with upfront fees. So far, Correlate has deployed this approach in the development of various solar energy projects around the United States. In April, for example, CIPI entered a contract worth more than $2 million for a major rooftop solar energy project in New Jersey (https://ibn.fm/8xu90). “Corporate America is stepping up their measurable actions to meet investor-driven ESG mandates. And why wouldn’t they? It’s tremendously profitable for them. In New Jersey, our clients will typically save at least 20% on day one while converting 70% of the facility’s electricity use to carbon-free solar energy,” said Correlate President and CEO Todd Michaels of the New Jersey project. “With Correlate, customers put up zero capital and simply get cheaper, clean power at a fixed price. That’s an infinite return.” Additionally, in May, CIPI announced it had been contracted to install a large-scale rooftop solar project at the headquarters of Continental Envelope (https://ibn.fm/hNKsS). Through projects such as these, Correlate Infrastructure Partners is not only contributing to the growth of renewable energy but also installing infrastructure that will enable states and the country to generate renewable electricity that meets 100% of their demand. For more information, visit the company’s website at www.CorrelateInfra.com.

• Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income: www.CorrelateInfra.com/our-process
• The company’s platform Generates New Rent and Operating Income, Allowing You to Meet Your ESG Goals: www.CorrelateInfra.com/program

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

• Eat Well closed the acquisition of Sapientia on July 31, 2021
• The acquisition was for a consideration of 3,741,969 common shares, and a cash payment of US$6.51 million in installments payable up to July 8, 2022
• Eat Well just paid its last installment of $840,000, marking a significant milestone for the company
• It now looks to continue building on Sapientia’s momentum by accelerating production and collaborating with other portfolio companies to meet existing and new demand, increase distribution and product offerings

In a study conducted by Gartner in 2019 on 473 Chief Executive Officers (“CEOs”) and senior business executives, 53% of the participants cited the growth of their businesses as their key priority going forward. They further noted that one of the fastest ways to grow their businesses was to enter new markets and reach previously inaccessible customers. Mergers and acquisitions (“M&A”), they said, would help achieve this objective while also exposing their businesses to more benefits associated with the move (https://ibn.fm/oh8k1). Consequently, M&A would define 2020 and 2021. In a 2022 mid-year update, PWC noted that at the start of 2022, dealmakers were “riding high from the best year on record for global M&A.” According to the report, 2021 saw over 60,000 publicly disclosed deals, valued at over US$5tn, a first in the history of M&As. Among the disclosed deals was Eat Well Investment Group’s (CSE: EWG) (OTC: EWGFF) acquisition of Sapientia Technology, LLC. (https://ibn.fm/aCXws). Closed on July 31, 2021, this acquisition was Eat Well’s move to disrupt the multibillion snack food market, gain access to new markets and reach new customers. At the time of the acquisition, Eat Well projected that Sapientia would generate approximately $1,133,000 in revenue for the 2021 financial year. Sapientia, Belle Pulses, and Amara organic foods would go on to post combined revenues of C$57,936,019 in 2021 (https://ibn.fm/rgzky). The consideration of the acquisition of Sapientia involved the issuance of 3,741,969 common shares and a cash payment of US$6.52 million to former Sapientia shareholders. On July 31, 2021, Eat Well paid US$1 million, with the remaining sum payable in installments up to July 8, 2022. Eat Well just finalized the payment of $840,000, the last installment fulfilling all outstanding payment obligations. According to the company’s management, completing this milestone allows Sapientia to further collaborate with other Eat Well portfolio companies to increase its margins and expand its product lines and flavors (https://ibn.fm/rXL0M). Since its acquisition, Sapientia has remained committed to becoming an industry leader in the snack market. It has created and filed four foundational patents revolving around the “Protein Twist” and crispy puff style snack, capitalizing on the initial success of the protein curls. In addition, the company has also launched a pilot program in Federated Co-op western Canada, evaluated multiple-tiered manufacturing solutions to scale the core product, and refined the business development pipeline for private labeling. Sapientia continues to develop an e-commerce pilot program via Amazon US for the second half of 2022 and plans to increase its store count in the third quarter of this fiscal year. Its management believes that maintaining the current momentum will allow the company to meet new demand while ultimately creating value for its shareholders. “Our objective is to continue building off our momentum by accelerating production to meet existing and new demand, and increase our distribution and product offerings,” noted Dr. Gino Bortone, the Founder and CEO of Sapientia. “We look forward to more innovation between Sapientia and Eat Well’s other portfolio investments at Belle Pulses and Amara,” noted Marc Aneed, Eat Well’s President and CEO. So far, Sapientia’s acquisition is paying off for Eat Well. The parent company has not only achieved growth through this acquisition but also stands to benefit from improved brand equity, a growing product list, and a broader market reach than ever before. This is proving beneficial to the company and its shareholders, even as Eat Well looks to push for its market expansion plans even more aggressively going forward. For more information, visit the company’s website at www.EatWellGroup.com. NOTE TO INVESTORS: The latest news and updates relating to EWGFF are available in the company’s newsroom at https://ibn.fm/EWGFF